Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Australia’s biggest healthcare companies, from global blood plasma giant CSL and surgical gloves supplier Ansell to sleep ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge ...

The start of patient dosing represents a huge milestone for Moleculin and, importantly, the AML community. “Our team rem ...

Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...

H-E-B joins a lawsuit with Kroger, Albertsons and Walgreens to sue a pharmaceutical company for conspiring to delay the ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...